Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise.
About 60% of American adults are “worried about being able to afford prescription drug costs for themselves or their families,” a recent KFF nationwide poll showed. More than 80% consider the price of prescription drugs “unreasonable,” and most support increased regulation to lower costs.
Americans pay about three times as much as people in other countries for the same prescription drugs. Last July, Trump sent letters to 17 drugmakers, demanding they voluntarily lower drug prices.
Then the president said he’d negotiated with more than a dozen pharmaceutical executives one by one at the White House. In December, he announced that he had compelled them to agree to “most favored nation” pricing on Medicaid, the government coverage for low-income Americans.
KFF Health News published a clinical update in Research Highlights on 07 May 2026.
The item focuses on Trump Promised Cheaper Drugs.
Some Prices Dropped.
Many Others Shot Up.
Review the original article for the full source wording and details.